Clinical efficacy of paclitaxel/cisplatin as an adjuvant chemotherapy for patients with cervical cancer who underwent radical hysterectomy and systematic lymphadenectomy.
Identifieur interne : 002123 ( PubMed/Checkpoint ); précédent : 002122; suivant : 002124Clinical efficacy of paclitaxel/cisplatin as an adjuvant chemotherapy for patients with cervical cancer who underwent radical hysterectomy and systematic lymphadenectomy.
Auteurs : Masayoshi Hosaka [Japon] ; Hidemichi Watari ; Tatsuya Kato ; Tetsuji Odagiri ; Yousuke Konno ; Daisuke Endo ; Takashi Mitamura ; Satomi Kikawa ; Yoshihiro Suzuki ; Noriaki SakuragiSource :
- Journal of surgical oncology [ 1096-9098 ] ; 2012.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Adénocarcinome (), Adénocarcinome (anatomopathologie), Carcinome épidermoïde (), Carcinome épidermoïde (anatomopathologie), Cisplatine (administration et posologie), Complications postopératoires, Femelle, Humains, Hystérectomie, Lymphadénectomie, Lymphoedème (étiologie), Occlusion intestinale (étiologie), Paclitaxel (administration et posologie), Protocoles de polychimiothérapie antinéoplasique (usage thérapeutique), Radiothérapie adjuvante, Récidive tumorale locale, Sujet âgé, Traitement médicamenteux adjuvant, Tumeurs du col de l'utérus (), Tumeurs du col de l'utérus (anatomopathologie), Études rétrospectives.
- MESH :
- administration et posologie : Cisplatine, Paclitaxel.
- anatomopathologie : Adénocarcinome, Carcinome épidermoïde, Tumeurs du col de l'utérus.
- usage thérapeutique : Protocoles de polychimiothérapie antinéoplasique.
- étiologie : Lymphoedème, Occlusion intestinale.
- Adulte, Adulte d'âge moyen, Adénocarcinome, Carcinome épidermoïde, Complications postopératoires, Femelle, Humains, Hystérectomie, Lymphadénectomie, Radiothérapie adjuvante, Récidive tumorale locale, Sujet âgé, Traitement médicamenteux adjuvant, Tumeurs du col de l'utérus, Études rétrospectives.
English descriptors
- KwdEn :
- Adenocarcinoma (pathology), Adenocarcinoma (therapy), Adult, Aged, Antineoplastic Combined Chemotherapy Protocols (therapeutic use), Carcinoma, Squamous Cell (pathology), Carcinoma, Squamous Cell (therapy), Chemotherapy, Adjuvant, Cisplatin (administration & dosage), Female, Humans, Hysterectomy, Intestinal Obstruction (etiology), Lymph Node Excision, Lymphedema (etiology), Middle Aged, Neoplasm Recurrence, Local, Paclitaxel (administration & dosage), Postoperative Complications, Radiotherapy, Adjuvant, Retrospective Studies, Uterine Cervical Neoplasms (pathology), Uterine Cervical Neoplasms (therapy).
- MESH :
- chemical , administration & dosage : Cisplatin, Paclitaxel.
- etiology : Intestinal Obstruction, Lymphedema.
- pathology : Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms.
- therapeutic use : Antineoplastic Combined Chemotherapy Protocols.
- therapy : Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms.
- Adult, Aged, Chemotherapy, Adjuvant, Female, Humans, Hysterectomy, Lymph Node Excision, Middle Aged, Neoplasm Recurrence, Local, Postoperative Complications, Radiotherapy, Adjuvant, Retrospective Studies.
Abstract
The aim of this study was to compare the clinical efficacy of paclitaxel/cisplatin (TP) as an adjuvant chemotherapy to adjuvant radiotherapy (RT) after radical hysterectomy and systematic lymphadenectomy for patients with cervical cancer.
DOI: 10.1002/jso.22136
PubMed: 22065519
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:22065519Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Clinical efficacy of paclitaxel/cisplatin as an adjuvant chemotherapy for patients with cervical cancer who underwent radical hysterectomy and systematic lymphadenectomy.</title><author><name sortKey="Hosaka, Masayoshi" sort="Hosaka, Masayoshi" uniqKey="Hosaka M" first="Masayoshi" last="Hosaka">Masayoshi Hosaka</name><affiliation wicri:level="1"><nlm:affiliation>Department of Obstetrics and Gynecology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Obstetrics and Gynecology, Hokkaido University Graduate School of Medicine, Sapporo</wicri:regionArea><wicri:noRegion>Sapporo</wicri:noRegion></affiliation></author><author><name sortKey="Watari, Hidemichi" sort="Watari, Hidemichi" uniqKey="Watari H" first="Hidemichi" last="Watari">Hidemichi Watari</name></author><author><name sortKey="Kato, Tatsuya" sort="Kato, Tatsuya" uniqKey="Kato T" first="Tatsuya" last="Kato">Tatsuya Kato</name></author><author><name sortKey="Odagiri, Tetsuji" sort="Odagiri, Tetsuji" uniqKey="Odagiri T" first="Tetsuji" last="Odagiri">Tetsuji Odagiri</name></author><author><name sortKey="Konno, Yousuke" sort="Konno, Yousuke" uniqKey="Konno Y" first="Yousuke" last="Konno">Yousuke Konno</name></author><author><name sortKey="Endo, Daisuke" sort="Endo, Daisuke" uniqKey="Endo D" first="Daisuke" last="Endo">Daisuke Endo</name></author><author><name sortKey="Mitamura, Takashi" sort="Mitamura, Takashi" uniqKey="Mitamura T" first="Takashi" last="Mitamura">Takashi Mitamura</name></author><author><name sortKey="Kikawa, Satomi" sort="Kikawa, Satomi" uniqKey="Kikawa S" first="Satomi" last="Kikawa">Satomi Kikawa</name></author><author><name sortKey="Suzuki, Yoshihiro" sort="Suzuki, Yoshihiro" uniqKey="Suzuki Y" first="Yoshihiro" last="Suzuki">Yoshihiro Suzuki</name></author><author><name sortKey="Sakuragi, Noriaki" sort="Sakuragi, Noriaki" uniqKey="Sakuragi N" first="Noriaki" last="Sakuragi">Noriaki Sakuragi</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="RBID">pubmed:22065519</idno><idno type="pmid">22065519</idno><idno type="doi">10.1002/jso.22136</idno><idno type="wicri:Area/PubMed/Corpus">002400</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002400</idno><idno type="wicri:Area/PubMed/Curation">002400</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002400</idno><idno type="wicri:Area/PubMed/Checkpoint">002400</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002400</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Clinical efficacy of paclitaxel/cisplatin as an adjuvant chemotherapy for patients with cervical cancer who underwent radical hysterectomy and systematic lymphadenectomy.</title><author><name sortKey="Hosaka, Masayoshi" sort="Hosaka, Masayoshi" uniqKey="Hosaka M" first="Masayoshi" last="Hosaka">Masayoshi Hosaka</name><affiliation wicri:level="1"><nlm:affiliation>Department of Obstetrics and Gynecology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Obstetrics and Gynecology, Hokkaido University Graduate School of Medicine, Sapporo</wicri:regionArea><wicri:noRegion>Sapporo</wicri:noRegion></affiliation></author><author><name sortKey="Watari, Hidemichi" sort="Watari, Hidemichi" uniqKey="Watari H" first="Hidemichi" last="Watari">Hidemichi Watari</name></author><author><name sortKey="Kato, Tatsuya" sort="Kato, Tatsuya" uniqKey="Kato T" first="Tatsuya" last="Kato">Tatsuya Kato</name></author><author><name sortKey="Odagiri, Tetsuji" sort="Odagiri, Tetsuji" uniqKey="Odagiri T" first="Tetsuji" last="Odagiri">Tetsuji Odagiri</name></author><author><name sortKey="Konno, Yousuke" sort="Konno, Yousuke" uniqKey="Konno Y" first="Yousuke" last="Konno">Yousuke Konno</name></author><author><name sortKey="Endo, Daisuke" sort="Endo, Daisuke" uniqKey="Endo D" first="Daisuke" last="Endo">Daisuke Endo</name></author><author><name sortKey="Mitamura, Takashi" sort="Mitamura, Takashi" uniqKey="Mitamura T" first="Takashi" last="Mitamura">Takashi Mitamura</name></author><author><name sortKey="Kikawa, Satomi" sort="Kikawa, Satomi" uniqKey="Kikawa S" first="Satomi" last="Kikawa">Satomi Kikawa</name></author><author><name sortKey="Suzuki, Yoshihiro" sort="Suzuki, Yoshihiro" uniqKey="Suzuki Y" first="Yoshihiro" last="Suzuki">Yoshihiro Suzuki</name></author><author><name sortKey="Sakuragi, Noriaki" sort="Sakuragi, Noriaki" uniqKey="Sakuragi N" first="Noriaki" last="Sakuragi">Noriaki Sakuragi</name></author></analytic><series><title level="j">Journal of surgical oncology</title><idno type="eISSN">1096-9098</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenocarcinoma (pathology)</term><term>Adenocarcinoma (therapy)</term><term>Adult</term><term>Aged</term><term>Antineoplastic Combined Chemotherapy Protocols (therapeutic use)</term><term>Carcinoma, Squamous Cell (pathology)</term><term>Carcinoma, Squamous Cell (therapy)</term><term>Chemotherapy, Adjuvant</term><term>Cisplatin (administration & dosage)</term><term>Female</term><term>Humans</term><term>Hysterectomy</term><term>Intestinal Obstruction (etiology)</term><term>Lymph Node Excision</term><term>Lymphedema (etiology)</term><term>Middle Aged</term><term>Neoplasm Recurrence, Local</term><term>Paclitaxel (administration & dosage)</term><term>Postoperative Complications</term><term>Radiotherapy, Adjuvant</term><term>Retrospective Studies</term><term>Uterine Cervical Neoplasms (pathology)</term><term>Uterine Cervical Neoplasms (therapy)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Adénocarcinome ()</term><term>Adénocarcinome (anatomopathologie)</term><term>Carcinome épidermoïde ()</term><term>Carcinome épidermoïde (anatomopathologie)</term><term>Cisplatine (administration et posologie)</term><term>Complications postopératoires</term><term>Femelle</term><term>Humains</term><term>Hystérectomie</term><term>Lymphadénectomie</term><term>Lymphoedème (étiologie)</term><term>Occlusion intestinale (étiologie)</term><term>Paclitaxel (administration et posologie)</term><term>Protocoles de polychimiothérapie antinéoplasique (usage thérapeutique)</term><term>Radiothérapie adjuvante</term><term>Récidive tumorale locale</term><term>Sujet âgé</term><term>Traitement médicamenteux adjuvant</term><term>Tumeurs du col de l'utérus ()</term><term>Tumeurs du col de l'utérus (anatomopathologie)</term><term>Études rétrospectives</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Cisplatin</term><term>Paclitaxel</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Cisplatine</term><term>Paclitaxel</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Adénocarcinome</term><term>Carcinome épidermoïde</term><term>Tumeurs du col de l'utérus</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Intestinal Obstruction</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Adenocarcinoma</term><term>Carcinoma, Squamous Cell</term><term>Uterine Cervical Neoplasms</term></keywords><keywords scheme="MESH" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Adenocarcinoma</term><term>Carcinoma, Squamous Cell</term><term>Uterine Cervical Neoplasms</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Protocoles de polychimiothérapie antinéoplasique</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term><term>Occlusion intestinale</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Chemotherapy, Adjuvant</term><term>Female</term><term>Humans</term><term>Hysterectomy</term><term>Lymph Node Excision</term><term>Middle Aged</term><term>Neoplasm Recurrence, Local</term><term>Postoperative Complications</term><term>Radiotherapy, Adjuvant</term><term>Retrospective Studies</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Adénocarcinome</term><term>Carcinome épidermoïde</term><term>Complications postopératoires</term><term>Femelle</term><term>Humains</term><term>Hystérectomie</term><term>Lymphadénectomie</term><term>Radiothérapie adjuvante</term><term>Récidive tumorale locale</term><term>Sujet âgé</term><term>Traitement médicamenteux adjuvant</term><term>Tumeurs du col de l'utérus</term><term>Études rétrospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The aim of this study was to compare the clinical efficacy of paclitaxel/cisplatin (TP) as an adjuvant chemotherapy to adjuvant radiotherapy (RT) after radical hysterectomy and systematic lymphadenectomy for patients with cervical cancer.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22065519</PMID><DateCreated><Year>2012</Year><Month>04</Month><Day>10</Day></DateCreated><DateCompleted><Year>2012</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-9098</ISSN><JournalIssue CitedMedium="Internet"><Volume>105</Volume><Issue>6</Issue><PubDate><Year>2012</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of surgical oncology</Title><ISOAbbreviation>J Surg Oncol</ISOAbbreviation></Journal><ArticleTitle>Clinical efficacy of paclitaxel/cisplatin as an adjuvant chemotherapy for patients with cervical cancer who underwent radical hysterectomy and systematic lymphadenectomy.</ArticleTitle><Pagination><MedlinePgn>612-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jso.22136</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES" NlmCategory="OBJECTIVE">The aim of this study was to compare the clinical efficacy of paclitaxel/cisplatin (TP) as an adjuvant chemotherapy to adjuvant radiotherapy (RT) after radical hysterectomy and systematic lymphadenectomy for patients with cervical cancer.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 125 patients with early-stage cervical cancer, who underwent radical hysterectomy, and received adjuvant therapy due to recurrent risk factors were retrospectively analyzed. Forty-nine patients were treated with RT, and 32 received paclitaxel/cisplatin (TP) for three to six cycles at 4-week interval. Survival and postoperative complications were compared between two modalities.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There was no significant difference of 3-year disease-free survival between two groups (P = 0.23), while significantly better 3-year overall survival in TP group than RT group (P = 0.02). Seven of 32 patients (21.9%) treated with adjuvant TP, 16 of 49 patients (32.7%) treated with RT showed disease recurrence. Median of survival time after recurrence in RT group and TP group was 8.5 months, 12.0 months, respectively. Postoperative bowel obstruction was significantly more frequent in the RT group compared to the TP group (P = 0.01).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Postoperative chemotherapy using TP might be more beneficial for survival than adjuvant RT and can reduce postoperative complications for cervical cancer patients treated with radical hysterectomy.</AbstractText><CopyrightInformation>Copyright © 2011 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hosaka</LastName><ForeName>Masayoshi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watari</LastName><ForeName>Hidemichi</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Kato</LastName><ForeName>Tatsuya</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Odagiri</LastName><ForeName>Tetsuji</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Konno</LastName><ForeName>Yousuke</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Endo</LastName><ForeName>Daisuke</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Mitamura</LastName><ForeName>Takashi</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Kikawa</LastName><ForeName>Satomi</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Suzuki</LastName><ForeName>Yoshihiro</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Sakuragi</LastName><ForeName>Noriaki</ForeName><Initials>N</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>11</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Surg Oncol</MedlineTA><NlmUniqueID>0222643</NlmUniqueID><ISSNLinking>0022-4790</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>P88XT4IS4D</RegistryNumber><NameOfSubstance UI="D017239">Paclitaxel</NameOfSubstance></Chemical><Chemical><RegistryNumber>Q20Q21Q62J</RegistryNumber><NameOfSubstance UI="D002945">Cisplatin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000230" MajorTopicYN="N">Adenocarcinoma</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002294" MajorTopicYN="N">Carcinoma, Squamous Cell</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017024" MajorTopicYN="N">Chemotherapy, Adjuvant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002945" MajorTopicYN="N">Cisplatin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007044" MajorTopicYN="Y">Hysterectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007415" MajorTopicYN="N">Intestinal Obstruction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="Y">Lymph Node Excision</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017239" MajorTopicYN="N">Paclitaxel</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018714" MajorTopicYN="N">Radiotherapy, Adjuvant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002583" MajorTopicYN="N">Uterine Cervical Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>04</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2011</Year><Month>09</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22065519</ArticleId><ArticleId IdType="doi">10.1002/jso.22136</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Japon</li></country></list><tree><noCountry><name sortKey="Endo, Daisuke" sort="Endo, Daisuke" uniqKey="Endo D" first="Daisuke" last="Endo">Daisuke Endo</name><name sortKey="Kato, Tatsuya" sort="Kato, Tatsuya" uniqKey="Kato T" first="Tatsuya" last="Kato">Tatsuya Kato</name><name sortKey="Kikawa, Satomi" sort="Kikawa, Satomi" uniqKey="Kikawa S" first="Satomi" last="Kikawa">Satomi Kikawa</name><name sortKey="Konno, Yousuke" sort="Konno, Yousuke" uniqKey="Konno Y" first="Yousuke" last="Konno">Yousuke Konno</name><name sortKey="Mitamura, Takashi" sort="Mitamura, Takashi" uniqKey="Mitamura T" first="Takashi" last="Mitamura">Takashi Mitamura</name><name sortKey="Odagiri, Tetsuji" sort="Odagiri, Tetsuji" uniqKey="Odagiri T" first="Tetsuji" last="Odagiri">Tetsuji Odagiri</name><name sortKey="Sakuragi, Noriaki" sort="Sakuragi, Noriaki" uniqKey="Sakuragi N" first="Noriaki" last="Sakuragi">Noriaki Sakuragi</name><name sortKey="Suzuki, Yoshihiro" sort="Suzuki, Yoshihiro" uniqKey="Suzuki Y" first="Yoshihiro" last="Suzuki">Yoshihiro Suzuki</name><name sortKey="Watari, Hidemichi" sort="Watari, Hidemichi" uniqKey="Watari H" first="Hidemichi" last="Watari">Hidemichi Watari</name></noCountry><country name="Japon"><noRegion><name sortKey="Hosaka, Masayoshi" sort="Hosaka, Masayoshi" uniqKey="Hosaka M" first="Masayoshi" last="Hosaka">Masayoshi Hosaka</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002123 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002123 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:22065519
|texte= Clinical efficacy of paclitaxel/cisplatin as an adjuvant chemotherapy for patients with cervical cancer who underwent radical hysterectomy and systematic lymphadenectomy.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:22065519" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |